Exact Mass: 434.23112740000005
Exact Mass Matches: 434.23112740000005
Found 500 metabolites which its exact mass value is equals to given mass value 434.23112740000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dexamethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3264 CONFIDENCE standard compound; INTERNAL_ID 2835
Extracort
CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8728; ORIGINAL_PRECURSOR_SCAN_NO 8723 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8791; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8741; ORIGINAL_PRECURSOR_SCAN_NO 8739 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8700; ORIGINAL_PRECURSOR_SCAN_NO 8699 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8788; ORIGINAL_PRECURSOR_SCAN_NO 8786 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8777; ORIGINAL_PRECURSOR_SCAN_NO 8775 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents CONFIDENCE standard compound; INTERNAL_ID 2826 D000893 - Anti-Inflammatory Agents
Flunisolide
Flunisolide is only found in individuals that have used or taken this drug. It is a corticosteroid often prescribed as treatment for allergic rhinitis.Flunisolide is a glucocorticoid receptor agonist. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Flunisolide binds to plasma transcortin, and it becomes active when it is not bound to transcortin. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents CONFIDENCE standard compound; INTERNAL_ID 2812 D000893 - Anti-Inflammatory Agents
Paramethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D01229
Glutathionylspermidine
C17H34N6O5S (434.23112740000005)
The spermidine amide of glutathione.
9alpha-Fluoro-6alpha-methylprednisolone 21-acetate
Lexibulin
C24H30N6O2 (434.24301199999996)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
LysoPA(0:0/18:2(9Z,12Z))
LysoPA(0:0/18:2(9Z,12Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
LysoPA(18:2(9Z,12Z)/0:0)
LPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LysoPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
4,5-Dihydro-drospirenone-3-sulfate
C24H34O5S (434.21268340000006)
4,5-Dihydro-drospirenone-3-sulfate is a metabolite of drospirenone. Drospirenone, also known as 1,2-dihydrospirorenone, is synthetic, steroidal progestin with additional antimineralocorticoid and weak antiandrogen properties which is used as a hormonal contraceptive. It is sold under the brand names Yasmin, Yasminelle, Yaz, Beyaz, Ocella, and Angeliq, all of which are combination products of drospirenone with an estrogen such as ethinylestradiol. (Wikipedia)
Dexamethasone acetate
(2s)-2-[[(2s)-2-Acetamido-5-[[n-(Methylcarbamoyl)carbamimidoyl]amino]pentanoyl]-Methyl-Amino]-3-Phenyl-Propanoic Acid
11-(Dansylamino)undecanoic acid
C23H34N2O4S (434.22391640000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003619 - Dansyl Compounds D004396 - Coloring Agents > D005456 - Fluorescent Dyes
Kenalog
Lexibulin
C24H30N6O2 (434.24301199999996)
Nasalide
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
Paramethasone acetate
Lophanthoidin F
DAUDA
C23H34N2O4S (434.22391640000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003619 - Dansyl Compounds D004396 - Coloring Agents > D005456 - Fluorescent Dyes
6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one
(all-Z)-5,7-dihydroxy-2-nonadeca-4,7,10,13,16-pentenyl-chromone|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaen-1-yl)-4H-chromen-4-one|5,7-dihydroxy-2-((4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenyl)-4H-chromen-4-one|5,7-dihydroxy-2-(4Z,7Z,10Z,13Z,16Z-nonadecapentaenyl)chromone
3-acetyleriocasin C|3beta,19-diacetoxy-6beta-hydroxy-7,16-dioxo-ent-abieta-15(17)-ene
3beta,19-diacetoxy-7alpha,14beta-dihydroxy-ent-kaur-16-en-15-one|pharicinin C
1alpha-(beta-D-glucopyranosyloxy)eudesma-3alpha,4beta,11-triol
2-Benzoyl-3,5-dihydroxy-4,4,6-tris(3-methyl-2-butenyl)-2,5-cyclohexadien-1-one
3alpha-hydroxy-2alpha-succinyloxy-labda-3,13-dien-15,16-olide
1alpha-Hydroxy-6-O-isobutyryl-3beta-(2-methylbutyryloxy)steiractinolid
17-hydroxy-7beta-succinyloxy-ent-cleroda-3,13-dien-15,16-olide
16-(4,9-dihydro-3H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|3,4-Dihydro-usambarensin
2alpha,10alpha-diacetoxy-7,8,18,19-diepoxydolabell-3(E)-en-14-one
6alpha,17alpha-dihydroxy-15,17-oxidospongian-16-one 6,17-diacetate
(1R*,4S*,4aR*.6S*)-6-acetoxy-4-((5R)-5-acetoxy-1-methylenehexyl)-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-3-one|(1R*,4S*,4aR*.6S*)-6-acetoxy-4-<(5R)-5-acetoxy-1-methylenehexyl>-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano<3,4-c>pyran-3-one
(1RS,5RS,7RS)-3-benzoyl-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione|garciniaphenone
(10R,6E)-7,11-dimethyl-3-methylene-6-dodecaene-1,2,10,11-tetraol 10-O-beta-D-glucopyranoside|trikamsesquiside A
7-epi-uprolide-C diacetate|Di-Ac-(1S,3R,4R,7S,12S,13R,14R)-3,4-Epoxy-7,13-dihyroxy-8(19),15(17)-cembradien-16,14-olide
14alpha,17-diacetoxymulin-12-ene-11-one-20-oic acid|mulinone a
12alpha,14beta-dihydroxy-7alpha,18-diacetoxy-ent-kaur-16-en-15-one|wikstroemioidin G
11alpha,17-diacetoxymulin-12-en-14-one-20-oic acid|mulinone b
6,19-Di-Ac-2,6,19-Trihydroxy-8,13-labdadien-15,16-olide
3beta,11beta-diacetoxy-2beta,6alpha-dihydroxy-ent-kaur-16-en-15-one|taibairubescensin B
3beta,11beta-dihydroxy-6alpha,7beta-diacetoxy-ent-kaur-16-en-15-one|xindongnin C
Rosthornin B
6beta,19-diacetoxy-1alpha,15beta-dihydroxy-ent-kaur-16-en-7-one|maoesin E
Betamethasone Acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2032 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3244
13-oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one
C24H34O7_{(1R,4aR,5S,6R,8S,8aR)-8-Acetoxy-5,6-dimethyl-5-[(2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-8aH-spiro[naphthalene-1,2-oxiran]-8a-yl}methyl acetate
Triamcinolone acetonide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based: Match]
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847678]
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847677]
Ala Phe Pro Thr
Ala Phe Thr Pro
Ala Ile Met Thr
C18H34N4O6S (434.21989440000004)
Ala Ile Thr Met
C18H34N4O6S (434.21989440000004)
Ala Leu Met Thr
C18H34N4O6S (434.21989440000004)
Ala Leu Thr Met
C18H34N4O6S (434.21989440000004)
Ala Met Ile Thr
C18H34N4O6S (434.21989440000004)
Ala Met Leu Thr
C18H34N4O6S (434.21989440000004)
Ala Met Thr Ile
C18H34N4O6S (434.21989440000004)
Ala Met Thr Leu
C18H34N4O6S (434.21989440000004)
Ala Pro Phe Thr
Ala Pro Thr Phe
Ala Thr Phe Pro
Ala Thr Ile Met
C18H34N4O6S (434.21989440000004)
Ala Thr Leu Met
C18H34N4O6S (434.21989440000004)
Ala Thr Met Ile
C18H34N4O6S (434.21989440000004)
Ala Thr Met Leu
C18H34N4O6S (434.21989440000004)
Ala Thr Pro Phe
Cys Gly Lys Lys
C17H34N6O5S (434.23112740000005)
Cys Ile Ile Ser
C18H34N4O6S (434.21989440000004)
Cys Ile Leu Ser
C18H34N4O6S (434.21989440000004)
Cys Ile Ser Ile
C18H34N4O6S (434.21989440000004)
Cys Ile Ser Leu
C18H34N4O6S (434.21989440000004)
Cys Ile Thr Val
C18H34N4O6S (434.21989440000004)
Cys Ile Val Thr
C18H34N4O6S (434.21989440000004)
Cys Lys Gly Lys
C17H34N6O5S (434.23112740000005)
Cys Lys Lys Gly
C17H34N6O5S (434.23112740000005)
Cys Leu Ile Ser
C18H34N4O6S (434.21989440000004)
Cys Leu Leu Ser
C18H34N4O6S (434.21989440000004)
Cys Leu Ser Ile
C18H34N4O6S (434.21989440000004)
Cys Leu Ser Leu
C18H34N4O6S (434.21989440000004)
Cys Leu Thr Val
C18H34N4O6S (434.21989440000004)
Cys Leu Val Thr
C18H34N4O6S (434.21989440000004)
Cys Ser Ile Ile
C18H34N4O6S (434.21989440000004)
Cys Ser Ile Leu
C18H34N4O6S (434.21989440000004)
Cys Ser Leu Ile
C18H34N4O6S (434.21989440000004)
Cys Ser Leu Leu
C18H34N4O6S (434.21989440000004)
Cys Thr Ile Val
C18H34N4O6S (434.21989440000004)
Cys Thr Leu Val
C18H34N4O6S (434.21989440000004)
Cys Thr Val Ile
C18H34N4O6S (434.21989440000004)
Cys Thr Val Leu
C18H34N4O6S (434.21989440000004)
Cys Val Ile Thr
C18H34N4O6S (434.21989440000004)
Cys Val Leu Thr
C18H34N4O6S (434.21989440000004)
Cys Val Thr Ile
C18H34N4O6S (434.21989440000004)
Cys Val Thr Leu
C18H34N4O6S (434.21989440000004)
Phe Ala Pro Thr
Phe Ala Thr Pro
Phe Pro Ala Thr
Phe Pro Thr Ala
Phe Thr Ala Pro
Phe Thr Pro Ala
Phe Val Ile Gly
Gly Cys Lys Lys
C17H34N6O5S (434.23112740000005)
Gly Lys Cys Lys
C17H34N6O5S (434.23112740000005)
Gly Lys Lys Cys
C17H34N6O5S (434.23112740000005)
Gly Pro Val Tyr
Gly Pro Tyr Val
Gly Val Pro Tyr
Gly Val Tyr Pro
Gly Tyr Pro Val
Gly Tyr Val Pro
Ile Ala Met Thr
C18H34N4O6S (434.21989440000004)
Ile Ala Thr Met
C18H34N4O6S (434.21989440000004)
Ile Cys Ile Ser
C18H34N4O6S (434.21989440000004)
Ile Cys Leu Ser
C18H34N4O6S (434.21989440000004)
Ile Cys Ser Ile
C18H34N4O6S (434.21989440000004)
Ile Cys Ser Leu
C18H34N4O6S (434.21989440000004)
Ile Cys Thr Val
C18H34N4O6S (434.21989440000004)
Ile Cys Val Thr
C18H34N4O6S (434.21989440000004)
Ile Ile Cys Ser
C18H34N4O6S (434.21989440000004)
Ile Ile Ser Cys
C18H34N4O6S (434.21989440000004)
Ile Leu Cys Ser
C18H34N4O6S (434.21989440000004)
Ile Leu Ser Cys
C18H34N4O6S (434.21989440000004)
Ile Met Ala Thr
C18H34N4O6S (434.21989440000004)
Ile Met Thr Ala
C18H34N4O6S (434.21989440000004)
Ile Ser Cys Ile
C18H34N4O6S (434.21989440000004)
Ile Ser Cys Leu
C18H34N4O6S (434.21989440000004)
Ile Ser Ile Cys
C18H34N4O6S (434.21989440000004)
Ile Ser Leu Cys
C18H34N4O6S (434.21989440000004)
Ile Thr Ala Met
C18H34N4O6S (434.21989440000004)
Ile Thr Cys Val
C18H34N4O6S (434.21989440000004)
Ile Thr Met Ala
C18H34N4O6S (434.21989440000004)
Ile Thr Thr Thr
Ile Thr Val Cys
C18H34N4O6S (434.21989440000004)
Ile Val Cys Thr
C18H34N4O6S (434.21989440000004)
Ile Val Thr Cys
C18H34N4O6S (434.21989440000004)
Lys Cys Gly Lys
C17H34N6O5S (434.23112740000005)
Lys Cys Lys Gly
C17H34N6O5S (434.23112740000005)
Lys Gly Cys Lys
C17H34N6O5S (434.23112740000005)
Lys Gly Lys Cys
C17H34N6O5S (434.23112740000005)
Lys Lys Cys Gly
C17H34N6O5S (434.23112740000005)
Lys Lys Gly Cys
C17H34N6O5S (434.23112740000005)
Lys Asn Ser Ser
Lys Ser Asn Ser
Lys Ser Ser Asn
Leu Ala Met Thr
C18H34N4O6S (434.21989440000004)
Leu Ala Thr Met
C18H34N4O6S (434.21989440000004)
Leu Cys Ile Ser
C18H34N4O6S (434.21989440000004)
Leu Cys Leu Ser
C18H34N4O6S (434.21989440000004)
Leu Cys Ser Ile
C18H34N4O6S (434.21989440000004)
Leu Cys Ser Leu
C18H34N4O6S (434.21989440000004)
Leu Cys Thr Val
C18H34N4O6S (434.21989440000004)
Leu Cys Val Thr
C18H34N4O6S (434.21989440000004)
Leu Ile Cys Ser
C18H34N4O6S (434.21989440000004)
Leu Ile Ser Cys
C18H34N4O6S (434.21989440000004)
Leu Leu Cys Ser
C18H34N4O6S (434.21989440000004)
Leu Leu Ser Cys
C18H34N4O6S (434.21989440000004)
Leu Met Ala Thr
C18H34N4O6S (434.21989440000004)
Leu Met Thr Ala
C18H34N4O6S (434.21989440000004)
Leu Ser Cys Ile
C18H34N4O6S (434.21989440000004)
Leu Ser Cys Leu
C18H34N4O6S (434.21989440000004)
Leu Ser Ile Cys
C18H34N4O6S (434.21989440000004)
Leu Ser Leu Cys
C18H34N4O6S (434.21989440000004)
Leu Thr Ala Met
C18H34N4O6S (434.21989440000004)
Leu Thr Cys Val
C18H34N4O6S (434.21989440000004)
Leu Thr Met Ala
C18H34N4O6S (434.21989440000004)
Leu Thr Thr Thr
Leu Thr Val Cys
C18H34N4O6S (434.21989440000004)
Leu Val Cys Thr
C18H34N4O6S (434.21989440000004)
Leu Val Thr Cys
C18H34N4O6S (434.21989440000004)
Met Ala Ile Thr
C18H34N4O6S (434.21989440000004)
Met Ala Leu Thr
C18H34N4O6S (434.21989440000004)
Met Ala Thr Ile
C18H34N4O6S (434.21989440000004)
Met Ala Thr Leu
C18H34N4O6S (434.21989440000004)
Met Ile Ala Thr
C18H34N4O6S (434.21989440000004)
Met Ile Thr Ala
C18H34N4O6S (434.21989440000004)
Met Leu Ala Thr
C18H34N4O6S (434.21989440000004)
Met Leu Thr Ala
C18H34N4O6S (434.21989440000004)
Met Ser Val Val
C18H34N4O6S (434.21989440000004)
Met Thr Ala Ile
C18H34N4O6S (434.21989440000004)
Met Thr Ala Leu
C18H34N4O6S (434.21989440000004)
Met Thr Ile Ala
C18H34N4O6S (434.21989440000004)
Met Thr Leu Ala
C18H34N4O6S (434.21989440000004)
Met Val Ser Val
C18H34N4O6S (434.21989440000004)
Met Val Val Ser
C18H34N4O6S (434.21989440000004)
Asn Lys Ser Ser
Asn Ser Lys Ser
Asn Ser Ser Lys
Pro Ala Phe Thr
Pro Ala Thr Phe
Pro Phe Ala Thr
Pro Phe Thr Ala
Pro Gly Val Tyr
Pro Gly Tyr Val
Pro Thr Ala Phe
Pro Thr Phe Ala
Pro Val Gly Tyr
Pro Val Tyr Gly
Pro Tyr Gly Val
Pro Tyr Val Gly
Ser Cys Ile Ile
C18H34N4O6S (434.21989440000004)
Ser Cys Ile Leu
C18H34N4O6S (434.21989440000004)
Ser Cys Leu Ile
C18H34N4O6S (434.21989440000004)
Ser Cys Leu Leu
C18H34N4O6S (434.21989440000004)
Ser Ile Cys Ile
C18H34N4O6S (434.21989440000004)
Ser Ile Cys Leu
C18H34N4O6S (434.21989440000004)
Ser Ile Ile Cys
C18H34N4O6S (434.21989440000004)
Ser Ile Leu Cys
C18H34N4O6S (434.21989440000004)
Ser Lys Asn Ser
Ser Lys Ser Asn
Ser Leu Cys Ile
C18H34N4O6S (434.21989440000004)
Ser Leu Cys Leu
C18H34N4O6S (434.21989440000004)
Ser Leu Ile Cys
C18H34N4O6S (434.21989440000004)
Ser Leu Leu Cys
C18H34N4O6S (434.21989440000004)
Ser Met Val Val
C18H34N4O6S (434.21989440000004)
Ser Asn Lys Ser
Ser Asn Ser Lys
Ser Ser Lys Asn
Ser Ser Asn Lys
Ser Val Met Val
C18H34N4O6S (434.21989440000004)
Ser Val Val Met
C18H34N4O6S (434.21989440000004)
Thr Ala Phe Pro
Thr Ala Ile Met
C18H34N4O6S (434.21989440000004)
Thr Ala Leu Met
C18H34N4O6S (434.21989440000004)
Thr Ala Met Ile
C18H34N4O6S (434.21989440000004)
Thr Ala Met Leu
C18H34N4O6S (434.21989440000004)
Thr Ala Pro Phe
Thr Cys Ile Val
C18H34N4O6S (434.21989440000004)
Thr Cys Leu Val
C18H34N4O6S (434.21989440000004)
Thr Cys Val Ile
C18H34N4O6S (434.21989440000004)
Thr Cys Val Leu
C18H34N4O6S (434.21989440000004)
Thr Phe Ala Pro
Thr Phe Pro Ala
Thr Ile Ala Met
C18H34N4O6S (434.21989440000004)
Thr Ile Cys Val
C18H34N4O6S (434.21989440000004)
Thr Ile Met Ala
C18H34N4O6S (434.21989440000004)
Thr Ile Thr Thr
Thr Ile Val Cys
C18H34N4O6S (434.21989440000004)
Thr Leu Ala Met
C18H34N4O6S (434.21989440000004)
Thr Leu Cys Val
C18H34N4O6S (434.21989440000004)
Thr Leu Met Ala
C18H34N4O6S (434.21989440000004)
Thr Leu Thr Thr
Thr Leu Val Cys
C18H34N4O6S (434.21989440000004)
Thr Met Ala Ile
C18H34N4O6S (434.21989440000004)
Thr Met Ala Leu
C18H34N4O6S (434.21989440000004)
Thr Met Ile Ala
C18H34N4O6S (434.21989440000004)
Thr Met Leu Ala
C18H34N4O6S (434.21989440000004)
Thr Pro Ala Phe
Thr Pro Phe Ala
Thr Thr Ile Thr
Thr Thr Leu Thr
Thr Thr Thr Ile
Thr Thr Thr Leu
Thr Val Cys Ile
C18H34N4O6S (434.21989440000004)
Thr Val Cys Leu
C18H34N4O6S (434.21989440000004)
Thr Val Ile Cys
C18H34N4O6S (434.21989440000004)
Thr Val Leu Cys
C18H34N4O6S (434.21989440000004)
Val Cys Ile Thr
C18H34N4O6S (434.21989440000004)
Val Cys Leu Thr
C18H34N4O6S (434.21989440000004)
Val Cys Thr Ile
C18H34N4O6S (434.21989440000004)
Val Cys Thr Leu
C18H34N4O6S (434.21989440000004)
Val Gly Phe Leu
Val Gly Ile Phe
Val Gly Leu Phe
Val Gly Pro Tyr
Val Gly Tyr Pro
Val Ile Cys Thr
C18H34N4O6S (434.21989440000004)
Val Ile Phe Gly
Val Ile Gly Phe
Val Ile Thr Cys
C18H34N4O6S (434.21989440000004)
Val Leu Cys Thr
C18H34N4O6S (434.21989440000004)
Val Leu Phe Gly
Val Leu Gly Phe
Val Leu Thr Cys
C18H34N4O6S (434.21989440000004)
Val Met Ser Val
C18H34N4O6S (434.21989440000004)
Val Met Val Ser
C18H34N4O6S (434.21989440000004)
Val Pro Gly Tyr
Val Pro Tyr Gly
Val Ser Met Val
C18H34N4O6S (434.21989440000004)
Val Ser Val Met
C18H34N4O6S (434.21989440000004)
Val Thr Cys Ile
C18H34N4O6S (434.21989440000004)
Val Thr Cys Leu
C18H34N4O6S (434.21989440000004)
Val Thr Ile Cys
C18H34N4O6S (434.21989440000004)
Val Thr Leu Cys
C18H34N4O6S (434.21989440000004)
Val Val Ala Phe
Val Val Phe Ala
Val Val Met Ser
C18H34N4O6S (434.21989440000004)
Val Val Ser Met
C18H34N4O6S (434.21989440000004)
Val Tyr Gly Pro
Val Tyr Pro Gly
Tyr Gly Pro Val
Tyr Gly Val Pro
Tyr Pro Gly Val
Tyr Pro Val Gly
Tyr Val Gly Pro
Tyr Val Pro Gly
(R)-1-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYL-PROPYL)PIPERIDINE
chlorbenzoxamine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
1-N,4-N-bis(2-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
C24H30N6O2 (434.24301199999996)
butyl 2-methylprop-2-enoate,4-hydroxy-2-methylidenebutanoic acid,prop-2-enoic acid,styrene
5-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE
1-ethyl-2-[1,2,3,4-tetrahydro-1-(2-hydroxyethyl)-2,2,4-trimethyl-6-quinolyl]benz[cd]indolium chloride
sodium 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]ethyl sulphate
4-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE
Acrylic acid, butyl acrylate, 2-hydroxyethyl methacrylate, styrene polymer
2,4-diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Pyrimidine
1-N,4-N-bis(3-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
C24H30N6O2 (434.24301199999996)
(2-(7-(2-(4-Cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non-3-yl)ethyl)carbamic acid tert-butyl ester
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11beta,16alpha)-
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents
Fluperolone acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
1-{[1-(2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-2-(3-cyano-phenyl)-ethaneboronic acid
(2S)-2-amino-5-[[(2R)-1-[[2-[4-(3-aminopropylamino)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
C17H34N6O5S (434.23112740000005)
3-acetyleriocasin C, (rel)-
A natural product found in Isodon eriocalyx.
N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-5-oxazolecarboxamide
C25H30N4O3 (434.23177899999996)
N-[2-(cyclopentylamino)-2-oxoethyl]-4,7-dimethyl-N-(2-methylphenyl)-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide
C25H30N4O3 (434.23177899999996)
2-Amino-1-(dimethylamino)-4-(1-naphthalenyl)-5-oxo-7-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile
(2E,4E,8S,10E,12Z)-1-[(3E,5S)-5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,8-dimethyltetradeca-2,4,10,12-tetraen-1-olate
(2S)-2-[(4S,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
(2R)-2-[(4S,5S)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
2-[(3R,6aS,8S,10aS)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3R,6aR,8S,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8R,10aS)-1-(4-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-piperidin-1-ylethanone
2-[(3S,6aR,8S,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-cyclopropyl-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-6-oxo-12-(2-phenylethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(6S,7S,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H30N4O3 (434.23177899999996)
(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H30N4O3 (434.23177899999996)
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C25H30N4O3 (434.23177899999996)
[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone
C25H30N4O3 (434.23177899999996)
1-[(2S,3S)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
(2R)-2-[(4R,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
(2S)-2-[(4R,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
(2S)-2-[(4R,5S)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H34N2O4S (434.22391640000006)
2-cyclopropyl-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-cyclopropyl-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]acetamide
2-[(3R,6aR,8R,10aR)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8S,10aS)-1-[(4-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C25H30N4O3 (434.23177899999996)
(6S,7S,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H30N4O3 (434.23177899999996)
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C25H30N4O3 (434.23177899999996)
[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone
C25H30N4O3 (434.23177899999996)
1-[(2R,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
1-[(2S,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
(2S,4R,10S,14S,16S,18S)-10,14-dimethyl-5-oxospiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,2-oxolane]-7-sulonic acid
C24H34O5S (434.21268340000006)
6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one
13-Oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid
FLUNISOLIDE
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
1-Oleoylglycerone 3-phosphate
A 1-acylglycerone 3-phosphate in which the acyl group is specified as oleoyl.
lysophosphatidic acid 0:0/18:2(9Z,12Z)
A 2-acyl-sn-glycerol 3-phosphate having (9Z,12Z)-octadeca-9,12-dienoyl as the 2-O-acyl group.
1-linoleoyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate having linoleyl (9Z,12Z-octadecadienoyl) as the 1-O-acyl group.
1-Oleoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoyl-sn-glycero-3-phosphate.
1-stearoylglycerone 3-phosphate(2-)
A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phospho groups of 1-stearoylglycerone 3-phosphate; major species at pH 7.3.
2-Oleoyl-sn-glycero-3-phosphate(2-)
A 2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-oleoyl-sn-glycero-3-phosphate; major species at pH 7.3.